Financial statements Violapharm
Balance sheet of Violapharm
Company age:
Age:
5 y. 1 m. 7 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of VIOLAPHARM
|
Year
|
2021
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 2 858 967,52 | 2 858 792,56 | 2 858 821,58 |
| A. Fixed assets | 4 442,76 | 4 442,76 | 4 442,76 |
| B. Current assets | 2 854 524,76 | 2 854 349,80 | 2 854 378,82 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 |
| Total liabilities | 2 858 967,52 | 2 858 792,56 | 2 858 821,58 |
| A. Equity | 3 964,96 | 1 864,02 | 364,02 |
| B. Liabilities and provisions for liabilities | 2 855 002,56 | 2 856 928,54 | 2 858 457,56 |
| I. Long-term liabilities | - | - | - |
| II. Short-term liabilities | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.